The O O O O
record-breaking O O O O
rollout O O O O
of O O O O
the O O O O
COVID-19 O O O O
vaccines O O O O
just O O O O
nine O O O O
months O O O O
after O O O O
the O O O O
start O O O O
of O O O O
the O O O O
pandemic O O O O
was O O O O
nothing O O O O
short O O O O
of O O O O
miraculous. O O O O
Soon O O O O
enough, O O O O
though, O O O O
the O O O O
cracks O O O O
in O O O O
the O O O O
world's O O O O
distribution O O O O
infrastructure O O O O
began O O O O
to O O O O
show. O O O O
The Reason 3 O O
mRNA-based Reason 3 O O
vaccines Reason 3 O O
required Reason 3 O O
incredibly Reason 3 O O
low Reason 3 O O
temperatures Reason 3 O O
to Reason 3 O O
remain Reason 3 O O
viable, Reason 3 O O
but Reason 3 O O
as Reason 3 O O
the Reason 3 O O
vaccines Reason 3 O O
rolled Reason 3 O O
out Reason 3 O O
to Reason 3 O O
the Reason 3 O O
public, Reason 3 O O
reports Reason 3 O O
of Reason 3 O O
wasted Reason 3 O O
doses Reason 3 O O
that Reason 3 O O
had Reason 3 O O
thawed Reason 3 O O
in Reason 3 O O
transport Reason 3 O O
peppered Reason 3 O O
the Reason 3 O O
news. Reason 3 O O
Most Reason 3 O O
vaccines Reason 3 O O
and Reason 3 O O
biologic-based Reason 3 O O
drugs Reason 3 O O
in Reason 3 O O
use Reason 3 O O
today Reason 3 O O
require Reason 3 O O
some Reason 3 O O
form Reason 3 O O
of Reason 3 O O
cold Reason 3 O O
storage Reason 3 O O
and Reason 3 O O
transport. Reason 3 O O
Often, Reason 3 O O
this Reason 3 O O
cold Reason 3 O O
chain Reason 3 O O
infrastructure Reason 3 O O
is Reason 3 O O
not Reason 3 O O
available Reason 3 O O
in Reason 3 O O
resource Reason 3 O O
limited Reason 3 O O
or Reason 3 O O
remote Reason 3 O O
locations, Reason 3 O O
making Reason 3 O O
effective Reason 3 O O
vaccination Reason 3 O O
campaigns Reason 3 O O
and Reason 3 O O
drug Reason 3 O O
distribution Reason 3 O O
difficult. Reason 3 O O
"Access Reason 3 O O
to Reason 3 O O
medicines Reason 3 O O
is Reason 3 O O
a Reason 3 O O
big Reason 3 O O
issue Reason 3 O O
all Reason 3 O O
around Reason 3 O O
the Reason 3 O O
globe, Reason 3 O O
and Reason 3 O O
to Reason 3 O O
be Reason 3 O O
honest, Reason 3 O O
most Reason 3 O O
of Reason 3 O O
the Reason 3 O O
cost Reason 3 O O
of Reason 3 O O
these Reason 3 O O
medicines Reason 3 O O
is Reason 3 O O
wrapped Reason 3 O O
up Reason 3 O O
in Reason 3 O O
how Reason 3 O O
we Reason 3 O O
store Reason 3 O O
them," Reason 3 O O
said Reason 3 O O
Maria Reason 3 O O
Croyle, Reason 3 O O
a Reason 3 O O
pharmacist Reason 3 O O
and Reason 3 O O
drug Reason 3 O O
formulation Reason 3 O O
expert Reason 3 O O
at Reason 3 O O
the Reason 3 O O
University Reason 3 O O
of Reason 3 O O
Texas Reason 3 O O
at Reason 3 O O
Austin. Reason 3 O O
With O O O O
her O O O O
experience O O O O
using O O O O
freeze O O O O
drying O O O O
to O O O O
stabilize O O O O
viruses O O O O
for O O O O
gene O O O O
therapy, O O O O
Croyle O O O O
knew O O O O
that O O O O
there O O O O
had O O O O
to O O O O
be O O O O
a O O O O
solution. O O O O
One O O O O
night, O O O O
as O O O O
she O O O O
and O O O O
her O O O O
husband O O O O
were O O O O
watching O O O O
a O O O O
documentary O O O O
about O O O O
the O O O O
preservative O O O O
and O O O O
stabilizing O O O O
qualities O O O O
of O O O O
amber, O O O O
it O O O O
hit O O O O
her. O O O O
"We O O O O
were O O O O
like, O O O O
'Is O O O O
that O O O O
it? O O O O
We O O O O
need O O O O
to O O O O
create O O O O
our O O O O
own O O O O
amber,'" O O O O
she O O O O
said. O O O O
After O O O O
years O O O O
of O O O O
research O O O O
and O O O O
thousands O O O O
of O O O O
different O O O O
combinations O O O O
of O O O O
sugars, O O O O
polymers, O O O O
and O O O O
surfactants, O O O O
Croyle O O O O
and O O O O
her O O O O
team O O O O
developed O O O O
a O O O O
thin O O O O
film O O O O
technology O O O O
that O O O O
can O O O O
encapsulate O O O O
live O O O O
virus O O O O
vaccines, O O O O
bacteria, O O O O
gene O O O O
therapies, O O O O
and O O O O
even O O O O
antibody-based O O O O
drugs. O O O O
These O O O O
thin O O O O
films, O O O O
which O O O O
Croyle O O O O
now O O O O
also O O O O
develops O O O O
at O O O O
her O O O O
company O O O O
Jurata O O O O
Thin O O O O
Film, O O O O
remain O O O O
stable O O O O
at O O O O
room O O O O
temperature O O O O
for O O O O
months O O O O
and O O O O
can O O O O
be O O O O
administered O O O O
orally, O O O O
nasally, O O O O
or O O O O
resuspended O O O O
in O O O O
liquid O O O O
for O O O O
injection, O O O O
revolutionizing O O O O
the O O O O
way O O O O
vaccines O O O O
and O O O O
biologics O O O O
are O O O O
made O O O O
and O O O O
broadening O O O O
their O O O O
accessibility O O O O
